IL108259A - History of piperazine as antagonists to TH-5 - Google Patents

History of piperazine as antagonists to TH-5

Info

Publication number
IL108259A
IL108259A IL10825994A IL10825994A IL108259A IL 108259 A IL108259 A IL 108259A IL 10825994 A IL10825994 A IL 10825994A IL 10825994 A IL10825994 A IL 10825994A IL 108259 A IL108259 A IL 108259A
Authority
IL
Israel
Prior art keywords
piperazine
trans
cyclohex
methoxyphenyl
compound
Prior art date
Application number
IL10825994A
Other languages
English (en)
Hebrew (he)
Other versions
IL108259A0 (en
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of IL108259A0 publication Critical patent/IL108259A0/xx
Publication of IL108259A publication Critical patent/IL108259A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
IL10825994A 1993-01-06 1994-01-03 History of piperazine as antagonists to TH-5 IL108259A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939300194A GB9300194D0 (en) 1993-01-06 1993-01-06 Piperazine derivatives

Publications (2)

Publication Number Publication Date
IL108259A0 IL108259A0 (en) 1994-04-12
IL108259A true IL108259A (en) 1998-09-24

Family

ID=10728386

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10825994A IL108259A (en) 1993-01-06 1994-01-03 History of piperazine as antagonists to TH-5

Country Status (13)

Country Link
US (1) US5622951A (de)
EP (1) EP0677046B1 (de)
JP (1) JPH08505381A (de)
AT (1) ATE155133T1 (de)
AU (1) AU5711594A (de)
DE (1) DE69312091T2 (de)
DK (1) DK0677046T3 (de)
ES (1) ES2105617T3 (de)
GB (1) GB9300194D0 (de)
GR (1) GR3024430T3 (de)
IL (1) IL108259A (de)
PH (1) PH31304A (de)
WO (1) WO1994015928A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900415A (en) * 1994-11-07 1999-05-04 Pfizer Inc. Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US6313126B1 (en) 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
WO2000040579A1 (en) * 1999-01-07 2000-07-13 American Home Products Corporation New 1,4-disubstituted cyclohexane derivatives for the treatment of depression
US6200994B1 (en) 1999-01-07 2001-03-13 American Home Products Corp 1,4-Disubstituted cyclohexane derivatives for the treatment of depression
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
UY28538A1 (es) 2003-09-26 2005-04-29 Vertex Pharma Derivados de fenil-piperazina como moduladores de receptores muscarínicos
JP4596792B2 (ja) * 2004-02-24 2010-12-15 あすか製薬株式会社 5−ht1a作動作用と5−ht3拮抗作用を併有する薬剤
JP4981794B2 (ja) 2005-06-03 2012-07-25 アボット・ラボラトリーズ シクロブチルアミン誘導体
US7576110B2 (en) 2005-09-22 2009-08-18 Abbott Laboratories Benzothiazole cyclobutyl amine derivatives
CN103382174A (zh) 2006-06-23 2013-11-06 雅培制药有限公司 作为组胺h3受体调节物的环丙胺衍生物
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
GB201017345D0 (en) 2010-10-14 2010-11-24 Proximagen Ltd Receptor antagonists
CN106831541B (zh) 2011-11-18 2019-09-06 赫普泰雅治疗有限公司 毒蕈碱性m1受体激动剂
DK3277284T3 (da) 2015-04-02 2020-10-26 Proximagen Llc Hidtil ukendte terapier mod kræft
GB201513743D0 (en) 2015-08-03 2015-09-16 Heptares Therapeutics Ltd Muscarinic agonists
GB201617454D0 (en) 2016-10-14 2016-11-30 Heptares Therapeutics Limited Pharmaceutical compounds
US10259787B2 (en) 2016-10-14 2019-04-16 Heptares Therapeutics Limited Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
GB201810239D0 (en) 2018-06-22 2018-08-08 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201819960D0 (en) 2018-12-07 2019-01-23 Heptares Therapeutics Ltd Pharmaceutical compounds
GB202020191D0 (en) 2020-12-18 2021-02-03 Heptares Therapeutics Ltd Pharmaceutical compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354161A (en) * 1964-07-16 1967-11-21 Miles Lab 8alpha-(4-phenyl-1-piperazyl)-4alpha, 5, 6, 7, 8alpha-hexahydro-4h-1-benzopyrans and process
US3309370A (en) * 1964-07-16 1967-03-14 Miles Lab Bicycloalkyl piperazine derivatives and process
NL7314672A (de) * 1972-11-11 1974-05-14
UST100505I4 (en) * 1980-03-17 1981-04-07 Triazolo[4,3-a]pyridin-3(2H)-ones
US4975445A (en) * 1989-12-06 1990-12-04 Warner-Lambert Company Substituted cyclohexenes as central nervous system agents
US5047406A (en) * 1989-12-06 1991-09-10 Warner-Lambert Co. Substituted cyclohexanols as central nervous system agents
FR2689893A1 (fr) * 1992-04-09 1993-10-15 Rhone Poulenc Rorer Sa Dérivés de diphényl-1,1 hydroxy-3 (sila)cyclopentane, leur préparation et les médicaments les contenant.

Also Published As

Publication number Publication date
IL108259A0 (en) 1994-04-12
JPH08505381A (ja) 1996-06-11
ES2105617T3 (es) 1997-10-16
PH31304A (en) 1998-07-06
EP0677046A1 (de) 1995-10-18
DE69312091D1 (de) 1997-08-14
AU5711594A (en) 1994-08-15
GB9300194D0 (en) 1993-03-03
EP0677046B1 (de) 1997-07-09
WO1994015928A1 (en) 1994-07-21
GR3024430T3 (en) 1997-11-28
US5622951A (en) 1997-04-22
DK0677046T3 (da) 1997-09-01
DE69312091T2 (de) 1998-02-19
ATE155133T1 (de) 1997-07-15

Similar Documents

Publication Publication Date Title
EP0677046B1 (de) Piperazinderivate als 5-ht antagonisten
EP0345808B1 (de) 1-Indolylalkyl-4-(substituierte Pyridinyl)-Piperazine
CA1271475A (en) Pharmaceutical compositions having a psychotropic activity
IE921409A1 (en) Piperazine derivatives
TW200540169A (en) Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
IE65378B1 (en) Piperazine derivatives
EP0737189B1 (de) Heterozyklische verbindungen für die behandlung von kardiovaskular- und zentralnervensystem störungen
CA2263340A1 (en) Fused indolecarboxamides: dopamine receptor subtype specific ligands
GB2248616A (en) Diarylalkyl-4-aryl-piperazine derivatives
WO1998006717A9 (en) Fused indolecarboxamides: dopamine receptor subtype specific ligands
AU682768B2 (en) Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
US6414157B1 (en) 3-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
GB2277517A (en) N-[(2-aryl-phenyl)alkyl]-piperazine derivatives
EP0690845B1 (de) Piperazin derivate als 5-ht1a liganden
CA2141810A1 (en) Amide derivatives
WO1999021848A2 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
EA005160B1 (ru) НОВЫЕ СОЕДИНЕНИЯ ОКТАГИДРО-2H-ПИРИДО[1,2-α]ПИРАЗИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ, ИХ СОДЕРЖАЩИЕ
WO1988001270A1 (en) Pyridopyrimidinediones
EP0927163B1 (de) Herstellung von 1-butyl-4-piperidinylmethylamin
IE64632B1 (en) Piperazine derivatives
HUT77940A (hu) Biciklusos karboxamidszármazékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
CA2293480A1 (en) 2-aminoalkylaminoquinolines as dopamine d4 ligands
US6313141B1 (en) 2-aminoalkylaminoquinolines as dopamine D4 ligands
EP1674103A1 (de) Arylpiperazine Derivative als 5-HT1A Rezeptor Liganden
Cliffe et al. Piperazine derivatives as 5-HT 1A ligands

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force